{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:03:25Z","timestamp":1773770605268,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jiac.2026.102932","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:17:25Z","timestamp":1771258645000},"page":"102932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of baloxavir\/marboxil treatment and treatment with other anti-influenza agents in adult patients hospitalized for influenza: An internet-based, prospective, multicenter, cohort study in Japan"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5414-8148","authenticated-orcid":false,"given":"Masafumi","family":"Seki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Oya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Shiko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Tateda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3423-8343","authenticated-orcid":false,"given":"Jiro","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8679-1661","authenticated-orcid":false,"given":"Kosaku","family":"Komiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Kawana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Izumikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Ohmagari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0832-1939","authenticated-orcid":false,"given":"Mitsuhiro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4869-5548","authenticated-orcid":false,"given":"Takaya","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0696-5386","authenticated-orcid":false,"given":"Takahiro","family":"Takazono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Miki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitsugu","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6251-1696","authenticated-orcid":false,"given":"Hiroshi","family":"Kakeya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2222-1396","authenticated-orcid":false,"given":"Yuta","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9628-9125","authenticated-orcid":false,"given":"Tadashi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2026.102932_bib1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1164\/rccm.200909-1420OC","article-title":"Lung pathology in fatal novel human influenza A (H1N1) infection","volume":"181","author":"Mauad","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.jiac.2026.102932_bib2","first-page":"179","article-title":"Influenza 2023-2024 season in Japan","volume":"45","year":"2024","journal-title":"IASR"},{"key":"10.1016\/j.jiac.2026.102932_bib3","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/cid\/ciy874","article-title":"Clinical Practice Guidelines by the infectious diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2026.102932_bib4","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil investigators Group., Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2026.102932_bib5","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S1473-3099(20)30004-9","article-title":"Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomized, placebo-controlled, phase 3 trial","volume":"20","author":"Ison","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2026.102932_bib6","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/INF.0000000000002747","article-title":"Baloxavir marboxil single-dose treatment in influenza-infected children. A randomized, double-blind, active controlled phase 3 safety and efficacy trial (miniSTONE-2)","volume":"39","author":"Baker","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2026.102932_bib7","first-page":"131","article-title":"Reduced prescription of baloxavir after suspected prevalence of a baloxavir-resistant influenza virus strain and the emergence of SARS-CoV-2 in a tertiary Hospital in Japan","volume":"12","author":"Kamioka","year":"2020","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.jiac.2026.102932_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2019.e00650","article-title":"Adult influenza A (H3N2) with reduced susceptibility to baloxavir or peramivir cured after switching anti-influenza agents","volume":"18","author":"Seki","year":"2019","journal-title":"IDCases"},{"issue":"3","key":"10.1016\/j.jiac.2026.102932_bib9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jiac.2020.10.021","article-title":"Clinical manifestations of adult patients requiring influenza-associated hospitalization: a prospective multicenter cohort study in Japan via internet surveillance","volume":"27","author":"Ishida","year":"2021","journal-title":"J Infect Chemother"},{"issue":"7","key":"10.1016\/j.jiac.2026.102932_bib10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jiac.2022.02.001","article-title":"Clinical manifestations of hospitalized influenza patients without risk factors: a prospective multicenter cohort study in Japan via internet surveillance","volume":"28","author":"Ishida","year":"2022","journal-title":"J Infect Chemother"},{"issue":"5","key":"10.1016\/j.jiac.2026.102932_bib11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.resinv.2025.06.014","article-title":"The JRS guideline for the management of pneumonia in adults 2024","volume":"63","author":"Mukae","year":"2024","journal-title":"Respiratory Investigation"},{"issue":"75","key":"10.1016\/j.jiac.2026.102932_bib12","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1093\/jac\/dkaa252","article-title":"Clinical outcomes of baloxavir versus oseltamivir in patients hospitalized with influenza A","volume":"2","author":"Shah","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.jiac.2026.102932_bib13","first-page":"239","article-title":"Medical treatment for influenza inpatients and evaluation of anti-influenza agents at Takatsuki Red Cross Hospital (abstract in English)","volume":"9","author":"Goto","year":"2020","journal-title":"Ann Jpn Respirat Soci"},{"key":"10.1016\/j.jiac.2026.102932_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jiac.2023.10.017","article-title":"Comparison of clinical efficacy and safety of baloxavir marboxil versus oseltamivir as the treatment for influenza virus infections: a systematic review and meta-analysis","volume":"30","author":"Shiraishi","year":"2024","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2026.102932_bib15","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1080\/17512433.2021.1917378","article-title":"Neuraminidase inhibitors and single dose baloxavir are effective and safe in uncomplicated influenza: a meta-analysis of randomized controlled trials","volume":"14","author":"Tejada","year":"2021","journal-title":"Expet Rev Clin Pharmacol"},{"key":"10.1016\/j.jiac.2026.102932_bib16","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1473-3099(21)00469-2","article-title":"Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomized, parallel-group, double-blind, placebo-controlled, superiority trial","volume":"22","author":"Kumar","year":"2022","journal-title":"Lancet Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:54:00Z","timestamp":1773759240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X26000309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1341321X26000309"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102932","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of baloxavir\/marboxil treatment and treatment with other anti-influenza agents in adult patients hospitalized for influenza: An internet-based, prospective, multicenter, cohort study in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102932","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102932"}}